Toxicities of Antibody-Drug Conjugates in Breast Cancer: From Mechanistic Insights to Clinical Management.

Sisca L, Polito MG, Travisani A, Zannino F, Iuliani M, Tonini G, Pantano F

Open source

DOI
10.3390/pharmaceutics18070792
Published
2026 Jun 28
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18070792,
  title = {Toxicities of Antibody-Drug Conjugates in Breast Cancer: From Mechanistic Insights to Clinical Management.},
  author = {Sisca L and Polito MG and Travisani A and Zannino F and Iuliani M and Tonini G and Pantano F},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18070792},
  url = {https://doi.org/10.3390/pharmaceutics18070792}
}

RIS

TY  - JOUR
TI  - Toxicities of Antibody-Drug Conjugates in Breast Cancer: From Mechanistic Insights to Clinical Management.
AU  - Sisca L
AU  - Polito MG
AU  - Travisani A
AU  - Zannino F
AU  - Iuliani M
AU  - Tonini G
AU  - Pantano F
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18070792
UR  - https://doi.org/10.3390/pharmaceutics18070792
ER  - 

APA

L, S., MG, P., A, T., F, Z., M, I., G, T., & F, P. (2026). Toxicities of Antibody-Drug Conjugates in Breast Cancer: From Mechanistic Insights to Clinical Management.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18070792

Source records